KHWAJA TARIQ: Open Payments
NPI 1639466717 · FRIENDSWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 119 payments from 20 companies in 2025. Trend: 2023 $1,689 · 2024 $2,023 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $302 |
| Axsome Therapeutics, Inc. | 10 | $244 |
| Janssen Pharmaceuticals, Inc | 8 | $237 |
| ABBVIE INC. | 14 | $236 |
| Neurocrine BioSciences, Inc. | 6 | $190 |
| E.R. Squibb & Sons, L.L.C. | 10 | $181 |
| Almatica Pharma LLC | 10 | $177 |
| Alkermes, Inc. | 8 | $164 |
| Lundbeck LLC | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
Products named: CAPLYTA, Auvelity, VRAYLAR, INGREZZA, SPRAVATO, COBENFY, REXULTI, LOREEV XR.
Industry payments across TX — which companies pay providers there.
